Related Experiment Video

Updated: Mar 10, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.7K

Suppression of bromodomain-containing protein 4 by shRNA: A new approach for cancer treatment

Turan Kaya1, Berke Kahraman, Nurgeldi Bazarov

  • 1. tkaya2013@stu.turgutozal.edu.tr.

Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|December 6, 2016
PubMed
Abstract

Insights

Targeting BET bromodomains with RNA interference (RNAi) effectively halts cancer cell proliferation. This study highlights BET bromodomains as key targets in c-MYC-driven cancers and demonstrates the efficacy of RNAi for therapeutic development.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • MYC is a crucial transcription factor regulating approximately 15% of human genes.
  • The central role of c-MYC in cancer makes it a significant therapeutic target for anticancer drug development.

Purpose of the Study:

  • To investigate the role of acetyl-lysine binding modules (bromodomains) in c-MYC transcriptional activation.
  • To evaluate BET bromodomains as a therapeutic target in cancer.

Main Methods:

  • Utilized small hairpin RNAs (shRNAs) for sequence-specific inhibition of BET bromodomains.
  • Assessed the impact of BET bromodomain inhibition on cellular proliferation in various cancer cell lines.

Main Results:

  • Inhibition of BET bromodomains using shRNAs led to the cessation of cellular proliferation across different cancer cell lines.
  • Demonstrated the significant role of BET bromodomains in solid tumors.
  • Highlighted the effectiveness and ease of RNA interference (RNAi) for inhibiting bromodomain translation.

Conclusions:

  • BET bromodomain inhibition significantly impacts cancer cell proliferation.
  • BET bromodomains are established as a major therapeutic target in malignancies characterized by c-MYC activation.

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.4K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K